Glutathione regulation of tumor necrosis factor-α-induced NF-κB activation in skeletal muscle-derived L6 cells

Biochemical and Biophysical Research Communications

Volumn 237, Issue 3, 1997, Pages 645-649

  Sen, Chandan K ^a,b   Khanna, Savita ^a,b   Reznick, Abraham Z ^a,c   Roy, Sashwati ^a,b   Packer, Lester ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BUTHIONINE SULFOXIMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PYRROLIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL NUCLEUS; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN CELL; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

EID: 0031589552     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7206     Document Type: Article

References (31)

1. Akira S., Hirano T., Taga T., Kishimoto T. FASEB J. 4:1990;2860-2867.
2. Beutler B., Cerami A. Nature. 320:1986;584-558.
3. Fong Y., Moldawer L. L., Marano M., Wei H., Barber A., Manogue K., Tracey K. J., Kuo G., Fischman D. A., Cerami A. Am. J. Physiol. 256:1989;R659-R665.
4. Strassmann G., Fong M., Kenney J. S., Jacob C. O. J. Clin. Invest. 89:1992;1681-1684.
5. Spiegelman B. M., Hotamisligil G. S. Cell. 73:1993;625-627.
6. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Cell. 50:1987;555-563.
7. Tracey K. J., Morgello S., Koplin B., Fahey T. J. d., Fox J., Aledo A., Manogue K. R., Cerami A. J. Clin. Invest. 86:1990;2014-2024.
8. Costelli P., Carbo N., Tessitore L., Bagby G. J., Lopez-Soriano F. J., Argiles J. M., Baccino F. M. J. Clin. Invest. 92:1993;2783-2789.
9. Brenner D. A., Buck M., Feitelberg S. P., Chojkier M. J. Clin. Invest. 85:1990;248-255.
10. Cheng J., Turksen K., Yu Q. C., Schreiber H., Teng M., Fuchs E. Genes Dev. 6:1992;1444-1456.
11. Tracey K. J., Cerami A. Annu. Rev. Cell. Biol. 9:1993;317-343.
12. Pisters P. W., Pearlstone D. B. Crit. Rev. Clin. Lab. Sci. 30:1993;223-272.
13. Ronen N., Gross B., Ben-Shachar D., Livne E. Adv. Exp. Med. Biol. 398:1996;177-182.
14. Weinstock C., Konig D., Harnischmacher R., Keul J., Berg A., Northoff H. Med. Sci. Sports Exerc. 29:1997;345-354.
15. Sen C. K. J. Appl. Physiol. 79:1995;675-686.
16. Kondo H., Itokawa Y. Exercise and Oxygen Toxicity. 1994;Elsevier Science, Amsterdam. p. 319-342.
17. Collins T., Read M. A., Neish A. S., Whitley M. Z., Thanos D., Maniatis T. FASEB J. 9:1995;899-909.
18. Sen C. K., Roy S., Han D., Packer L. Free Radic. Biol. Med. 22:1997;1241-1257.
19. Sen C. K., Roy S., Packer L. FEBS Lett. 385:1996;58-62.
20. Sen C. K., Hanninen O., Orlov S. N. J. Appl. Physiol. 78:1995;272-281.
21. Frischer H., Ahmad T. J. Lab. Clin. Med. 89:1977;1080-1091.
22. Karplus P. A., Krauth-Siegel R. L., Schirmer R. H., Schulz G. E. Eur. J. Biochem. 171:1988;193-198.
23. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H. P., Roth S., Gmunder H. FASEB J. 8:1994;1131-1138.
24. Sen C. K., Packer L. FASEB J. 10:1996;709-720.
25. Feng L., Xia Y., Garcia G. E., Hwang D., Wilson C. B. J. Clin. Invest. 95:1995;1669-1675.
26. Sakaguchi S., Furusawa S., Yokota K., Sasaki K., Takayanagi M., Takayanagi Y. Pharmacol. Toxicol. 79:1996;259-265.
27. Muller J. M., Rupec R. A., Baeuerle P. A. Methods. 11:1997;301-312.
28. Buck M., Chojkier M. EMBO J. 15:1996;1753-1765.
29. Droge W., Gross A., Hack V., Kinscherf R., Schykowski M., Bockstette M., Mihm S., Galter D. Adv. Pharmacol. 38:1997;581-600.
30. Hack V., Gross A., Kinscherf R., Bockstette M., Fiers W., Berke G., Droge W. FASEB J. 10:1996;1219-1226.
31. Sen C. K., Packer L. Am. J. Clin. Nutr. 1997.